Literature DB >> 27043234

Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU.

Matteo Bassetti1, Garyphallia Poulakou2, Jean-François Timsit3,4.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27043234     DOI： 10.1007/s00134-016-4341-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  21 in total

1.  Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.

Authors:  Etienne de Montmollin; Lila Bouadma; Nathalie Gault; Bruno Mourvillier; Eric Mariotte; Sarah Chemam; Laurent Massias; Emmanuelle Papy; Florence Tubach; Michel Wolff; Romain Sonneville
Journal:  Intensive Care Med       Date:  2014-04-01       Impact factor: 17.440

2.  Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Francesco Giuseppe De Rosa; Maddalena Giannella; Daniele Roberto Giacobbe; Matteo Bassetti; Angela Raffaella Losito; Michele Bartoletti; Valerio Del Bono; Silvia Corcione; Giuseppe Maiuro; Sara Tedeschi; Luigi Celani; Chiara Simona Cardellino; Teresa Spanu; Anna Marchese; Simone Ambretti; Roberto Cauda; Claudio Viscoli; Pierluigi Viale
Journal:  J Antimicrob Chemother       Date:  2015-04-21       Impact factor: 5.790

3.  Ten tips on how to win the war against resistance to antibiotics.

Authors:  Jean Carlet
Journal:  Intensive Care Med       Date:  2015-01-09       Impact factor: 17.440

4.  Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration.

Authors:  Gennaro De Pascale; Serena Fortuna; Mario Tumbarello; Salvatore Lucio Cutuli; MariaSole Vallecoccia; Teresa Spanu; Giuseppe Bello; Luca Montini; Mariano Alberto Pennisi; Pierluigi Navarra; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2014-11-21       Impact factor: 17.440

5.  A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.

Authors:  Joel M Dulhunty; Jason A Roberts; Joshua S Davis; Steven A R Webb; Rinaldo Bellomo; Charles Gomersall; Charudatt Shirwadkar; Glenn M Eastwood; John Myburgh; David L Paterson; Therese Starr; Sanjoy K Paul; Jeffrey Lipman
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

6.  Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.

Authors:  Olivier Mimoz; Jean-Christophe Lucet; Thomas Kerforne; Julien Pascal; Bertrand Souweine; Véronique Goudet; Alain Mercat; Lila Bouadma; Sigismond Lasocki; Serge Alfandari; Arnaud Friggeri; Florent Wallet; Nicolas Allou; Stéphane Ruckly; Dorothée Balayn; Alain Lepape; Jean-François Timsit
Journal:  Lancet       Date:  2015-09-18       Impact factor: 79.321

7.  Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.

Authors:  Jan J De Waele; J Lipman; M Akova; M Bassetti; G Dimopoulos; M Kaukonen; D Koulenti; C Martin; P Montravers; J Rello; A Rhodes; A A Udy; T Starr; S C Wallis; J A Roberts
Journal:  Intensive Care Med       Date:  2014-07-23       Impact factor: 17.440

8.  Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study.

Authors:  Tjasa Hranjec; Laura H Rosenberger; Brian Swenson; Rosemarie Metzger; Tanya R Flohr; Amani D Politano; Lin M Riccio; Kimberley A Popovsky; Robert G Sawyer
Journal:  Lancet Infect Dis       Date:  2012-08-28       Impact factor: 25.071

Review 9.  Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria.

Authors:  Matteo Bassetti; Jan J De Waele; Philippe Eggimann; Josè Garnacho-Montero; Gunnar Kahlmeter; Francesco Menichetti; David P Nicolau; Jose Arturo Paiva; Mario Tumbarello; Tobias Welte; Mark Wilcox; Jean Ralph Zahar; Garyphallia Poulakou
Journal:  Intensive Care Med       Date:  2015-03-20       Impact factor: 17.440

10.  DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?

Authors:  Jason A Roberts; Sanjoy K Paul; Murat Akova; Matteo Bassetti; Jan J De Waele; George Dimopoulos; Kirsi-Maija Kaukonen; Despoina Koulenti; Claude Martin; Philippe Montravers; Jordi Rello; Andrew Rhodes; Therese Starr; Steven C Wallis; Jeffrey Lipman
Journal:  Clin Infect Dis       Date:  2014-01-14       Impact factor: 9.079
View more
  10 in total

1.  [Infections due to multidrug-resistant pathogens : Pathogens, resistance mechanisms and established treatment options].

Authors:  D C Richter; T Brenner; A Brinkmann; B Grabein; M Hochreiter; A Heininger; D Störzinger; J Briegel; M Pletz; M A Weigand; C Lichtenstern
Journal:  Anaesthesist       Date:  2019-10       Impact factor: 1.041

Review 2.  The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship.

Authors:  Marin H Kollef; Matteo Bassetti; Bruno Francois; Jason Burnham; George Dimopoulos; Jose Garnacho-Montero; Jeffrey Lipman; Charles-Edouard Luyt; David P Nicolau; Maarten J Postma; Antonio Torres; Tobias Welte; Richard G Wunderink
Journal:  Intensive Care Med       Date:  2017-02-04       Impact factor: 17.440

3.  The Meta-Substituted Isomer of TMPyP Enables More Effective Photodynamic Bacterial Inactivation than Para-TMPyP In Vitro.

Authors:  Sebastian Schulz; Svitlana Ziganshyna; Norman Lippmann; Sarah Glass; Volker Eulenburg; Natalia Habermann; Ulrich T Schwarz; Alexander Voigt; Claudia Heilmann; Tobias Rüffer; Robert Werdehausen
Journal:  Microorganisms       Date:  2022-04-21

Review 4.  Epigenetic-Mediated Antimicrobial Resistance: Host versus Pathogen Epigenetic Alterations.

Authors:  Jibran Sualeh Muhammad; Naveed Ahmed Khan; Sutherland K Maciver; Ahmad M Alharbi; Hasan Alfahemi; Ruqaiyyah Siddiqui
Journal:  Antibiotics (Basel)       Date:  2022-06-16

5.  Clinical epigenetics and multidrug-resistant bacterial infections: host remodelling in critical illness.

Authors:  Ettore Crimi; Giuditta Benincasa; Silvia Cirri; Rebecca Mutesi; Mario Faenza; Claudio Napoli
Journal:  Epigenetics       Date:  2020-04-14       Impact factor: 4.528

Review 6.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

Review 7.  Quality indicators in intensive care medicine for Germany - third edition 2017.

Authors:  Oliver Kumpf; Jan-Peter Braun; Alexander Brinkmann; Hanswerner Bause; Martin Bellgardt; Frank Bloos; Rolf Dubb; Clemens Greim; Arnold Kaltwasser; Gernot Marx; Reimer Riessen; Claudia Spies; Jörg Weimann; Gabriele Wöbker; Elke Muhl; Christian Waydhas
Journal:  Ger Med Sci       Date:  2017-08-01

8.  A complete and multifaceted overview of antibiotic use and infection diagnosis in the intensive care unit: results from a prospective four-year registration.

Authors:  Liesbet De Bus; Bram Gadeyne; Johan Steen; Jerina Boelens; Geert Claeys; Dominique Benoit; Jan De Waele; Johan Decruyenaere; Pieter Depuydt
Journal:  Crit Care       Date:  2018-09-29       Impact factor: 9.097

9.  Feasibility of Antimicrobial Stewardship (AMS) in Critical Care Settings: A Multidisciplinary Approach Strategy.

Authors:  Tamas Tiszai-Szucs; Claire Mac Sweeney; Joseph Keaveny; Fernando A Bozza; Zieta O Hagan; Ignacio Martin-Loeches
Journal:  Med Sci (Basel)       Date:  2018-05-25

10.  Evaluation of in Vitro Activity of Ceftazidime/Avibactam and Ceftolozane/Tazobactam against ESBL-producing Enterobacterales Isolated from Intensive Care Units from Qatar.

Authors:  Mazen A Sid Ahmed; Emad Bashir Ibrahim; Jemal M Hamid; Joanne Daghfal; Mohammed A Alyazidi; Aimen H Abdelwahab; Muna A Al-Maslamani; Abdul Latif Al Khal; Hamad Abdel Hadi
Journal:  Oman Med J       Date:  2022-09-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.